Sight Sciences, Inc. (SGHT )
Currency in USD Disclaimer
Subscribe Now for Delta3 AI Alerts
Don’t miss out on top stock picks and market insights. Subscribe to Delta3 AI Alerts for real-time updates and expert analysis straight to your inbox. Stay informed and maximize your investment potential.
Key Stats
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
- Symbol SGHT
- Company Sight Sciences, Inc.
- Price $7.47
- Changes Percentage 5.36
- Change 0.38
- Day Low $7.03
- Day High $7.6
- Year High $9.24
- Year Low $3.11
- Market Cap $286,196,074
- Price Avg 50 EMA (D) $5.06
- Price Avg 200 EMA (D) $5.5
- Exchange NASDAQ
- Volume 35,637
- Average Volume 190,393
- Open $7.24
- Previous Close $7.09
- EPS -0.71
- PE -7.41
- Earnings Announcement 2026-08-06 20:00:00
- Shares Outstanding $54,409,900
Company brief: SIGHT SCIENCES, INC. (SGHT )
- Healthcare
- Medical - Devices
- Mr. Paul Badawi
- https://www.sightsciences.com
- US
- N/A
- 07-15-2021
- US82657M1053
Sight Sciences, Inc., an ophthalmic medical device company, engages in the development and commercialization of surgical and nonsurgical technologies for the treatment of eye diseases. The company's products include OMNI Surgical System, a therapeutic device used by ophthalmic surgeons to reduce intraocular pressure in adult glaucoma patients; and TearCare System, a wearable eyelid technology for the treatment of dry eye disease (DED) for ophthalmologists and optometrists. It offers its products through sales representatives and distributors to hospitals, medical centers, and eyecare professionals in the United States. The company was incorporated in 2010 and is headquartered in Menlo Park, California.